Just Published: "Global Cancer Immunotherapies Market 2016-2020"

Cancer immunotherapy works by enhancing the innate powers of the immune system. This has better chances of successfully fighting cancer for a long period. Also, immunotherapies have fewer side effects and can treat different types of cancer. Cancer immunotherapies make up nearly 50% of the cancer drugs market.

Technavio's analysts forecast the global cancer immunotherapies market to grow at a CAGR of 15.17% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global cancer immunotherapies market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of cancer immunotherapies used to treat cancer.
The market is divided into the following segments based on geography:

* Americas
* APAC
* EMEA

Technavio's report, Global Cancer Immunotherapies Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Full Report Details at
- http://www.fastmr.com/prod/1170735_global_cancer_immunotherapies.aspx?afid=301

Key vendors

* Amgen
* Bristol-Myers Squibb
* F. Hoffmann-La Roche
* GlaxoSmithKline
* Merck
* Takeda Pharmaceuticals

Other prominent vendors

* AbbVie
* ADC Therapeutics
* Agensys
* Astellas
* AstraZeneca
* Bayer
* Biogen
* Biotech Pharmaceutical
* Boehringer-Ingelheim
* Celgene
* Celldex Therapeutics
* Chugai Pharmaceutical
* CTI Biopharma
* Daiichi Sankyo
* Eli Lilly
* Fortress Biotech
* Genmab
* Immunomedics
* Intas Pharmaceuticals
* Janssen Biotech
* Kyowa Hakko Kirin
* MedImmune
* Morphotek
* Neovii Biotech
* Novartis
* OncoMed Pharmaceuticals
* Pfizer
* Sanofi
* Seattle Genetics
* Spectrum Pharmaceuticals
* TG Therapeutics
* XBiotech

Market driver

* Increase in demand for cancer monoclonal antibodies
* For a full, detailed list, view our report

Market challenge

* Patent expiry of top-selling drugs
* For a full, detailed list, view our report

Market trend

* Emergence of targeted and combination therapies
* For a full, detailed list, view our report

Key questions answered in this report

* What will the market size be in 2020 and what will the growth rate be?
* What are the key market trends?
* What is driving this market?
* What are the challenges to market growth?
* Who are the key vendors in this market space?
* What are the market opportunities and threats faced by the key vendors?
* What are the strengths and weaknesses of the key vendors?

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Breast Cancer Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rapid Uptake of Premium Priced Biologics and Rising Incidence
- PharmaPoint: Prostate Cancer - Global Drug Forecast and Market Analysis to 2023
- Breast Cancer Therapeutics in Asia-Pacific Markets to 2021 - Growth Driven by Increasing Uptake of Premium Priced Biologics and Rising Prevalence
- Cancer Pain Global Clinical Trials Review, H1, 2015
- Pancreatic Cancer Therapeutics in Major Developed Markets to 2021 - Strong Late Stage Pipeline Holds Promise for Increasingly Diverse Market Landscape